News West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Market Closed - Nyse Other stock markets 04:00:01 2024-04-16 pm EDT			5-day change	1st Jan Change
379.5 ^USD	+0.18%		-3.29%	+7.77%

Mar. 29	Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	RE
Mar. 19	Transcript : West Pharmaceutical Services, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:00 AM

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

West to Host First-Quarter 2024 Conference Call	Apr. 11	PR
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE
Transcript : West Pharmaceutical Services, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:00 AM	Mar. 19
West Pharmaceutical Services : 2024 Proxy	Mar. 14	PU
Pacific Edge's Chair to Retire; Shares Fall 3%	Mar. 13	MT
West Pharmaceutical Services Inc Files a Definitive Proxy Statement	Mar. 13	CI
Transcript : West Pharmaceutical Services, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 01:05 PM	Mar. 12
West Pharmaceutical Services Insider Sold Shares Worth $292,436, According to a Recent SEC Filing	Mar. 12	MT
Accenture: acquisition of Australian company The Lumery	Mar. 04	CF
West Pharmaceutical Services Inc Receives a Shareholder Proposal from John Chevedden	Mar. 01	CI
West Pharmaceutical Services Insider Sold Shares Worth $724,061, According to a Recent SEC Filing	Mar. 01	MT
West to Participate in Upcoming Investor Conferences	Feb. 28	PR
West Pharmaceutical Services Insider Sold Shares Worth $2,559,380, According to a Recent SEC Filing	Feb. 27	MT
West Pharmaceutical Services Maintains Quarterly Dividend at $0.20 per Share; Payable May 1 to Holders of Record on April 24	Feb. 20	MT
West Announces Second-Quarter 2024 Dividend	Feb. 20	PR
West Pharmaceutical Services, Inc. Announces Second Quarter 2024 Dividend, Payable on May 1, 2024	Feb. 20	CI
UBS Cuts West Pharmaceutical Services Price Target to $375 From $400, Maintains Neutral Rating	Feb. 16	MT
Deutsche Bank Raises West Pharmaceutical Services Price Target to $355 From $350, Maintains Hold Rating	Feb. 16	MT
Forget about rate cuts...	Feb. 16
ANALYST RECOMMENDATIONS : Coinbase, Fortinet, Nike, Chipotle, Nvidia...	Feb. 16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News West Pharmaceutical Services, Inc.

Equities

WST

US9553061055

Summary

Filters